GR3024151T3 - Silylated acetylcholinesterase inhibitors. - Google Patents

Silylated acetylcholinesterase inhibitors.

Info

Publication number
GR3024151T3
GR3024151T3 GR970401801T GR970401801T GR3024151T3 GR 3024151 T3 GR3024151 T3 GR 3024151T3 GR 970401801 T GR970401801 T GR 970401801T GR 970401801 T GR970401801 T GR 970401801T GR 3024151 T3 GR3024151 T3 GR 3024151T3
Authority
GR
Greece
Prior art keywords
silylated
acetylcholinesterase inhibitors
compounds
methods
acetylcholinesterase
Prior art date
Application number
GR970401801T
Other languages
English (en)
Inventor
Jean-Noel Collard
Jean-Marie Hornsperger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of GR3024151T3 publication Critical patent/GR3024151T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
GR970401801T 1993-02-16 1997-07-16 Silylated acetylcholinesterase inhibitors. GR3024151T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400385A EP0611769A1 (en) 1993-02-16 1993-02-16 Silylated acetylcholinesterase inhibitors
PCT/US1994/000720 WO1994019356A1 (en) 1993-02-16 1994-01-25 Silylated acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
GR3024151T3 true GR3024151T3 (en) 1997-10-31

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401801T GR3024151T3 (en) 1993-02-16 1997-07-16 Silylated acetylcholinesterase inhibitors.

Country Status (19)

Country Link
EP (2) EP0611769A1 (el)
JP (1) JP3516955B2 (el)
KR (1) KR100336547B1 (el)
CN (1) CN1043575C (el)
AT (1) ATE152725T1 (el)
AU (1) AU672885B2 (el)
CA (1) CA2154870C (el)
DE (1) DE69403068T2 (el)
DK (1) DK0684951T3 (el)
ES (1) ES2104358T3 (el)
FI (1) FI111461B (el)
GR (1) GR3024151T3 (el)
HU (1) HUT72736A (el)
IL (1) IL108623A0 (el)
MX (1) MX9401175A (el)
NO (1) NO305517B1 (el)
NZ (1) NZ262247A (el)
WO (1) WO1994019356A1 (el)
ZA (1) ZA94925B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术(上海)有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
CA2772488C (en) 2009-09-11 2018-04-17 Probiodrug Ag Heterocyclic derivatives as inhibitors of glutaminyl cyclase
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
EP2545047B9 (en) 2010-03-10 2015-06-10 Probiodrug AG Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物,其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
DE69403068D1 (en) 1997-06-12
KR100336547B1 (ko) 2002-11-02
AU6164194A (en) 1994-09-14
EP0684951B1 (en) 1997-05-07
CA2154870A1 (en) 1994-09-01
EP0611769A1 (en) 1994-08-24
HUT72736A (en) 1996-05-28
DK0684951T3 (da) 1997-05-26
AU672885B2 (en) 1996-10-17
KR960701068A (ko) 1996-02-24
WO1994019356A1 (en) 1994-09-01
IL108623A0 (en) 1994-05-30
NO953201D0 (no) 1995-08-15
CN1117733A (zh) 1996-02-28
CA2154870C (en) 1998-10-27
ZA94925B (en) 1994-08-25
JP3516955B2 (ja) 2004-04-05
MX9401175A (es) 1994-08-31
NZ262247A (en) 1996-01-26
EP0684951A1 (en) 1995-12-06
ES2104358T3 (es) 1997-10-01
NO953201L (no) 1995-08-15
ATE152725T1 (de) 1997-05-15
DE69403068T2 (de) 1997-12-11
FI953851A0 (fi) 1995-08-15
JPH08507059A (ja) 1996-07-30
FI953851A (fi) 1995-08-15
NO305517B1 (no) 1999-06-14
CN1043575C (zh) 1999-06-09
FI111461B (fi) 2003-07-31

Similar Documents

Publication Publication Date Title
HU9503452D0 (en) Aromatic acetylcholinesterase inhibitors
IL108623A0 (en) Silylated acetylcholinesterase inhibitors
EP0627221A3 (en) Substance P antagonists used to treat vomiting.
ZA937244B (en) Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus
EP0630383A4 (en) METHODS OF TREATING DIABETES.
EP0710106A4 (en) METHOD FOR TREATING ADDICTIVE BEHAVIOR
HU9301169D0 (en) Method for improving flame-proofness of plastics by means of addition of guanidine-barbiturates and/or guanidine-thiobarbiturates as burning inhibitors, flame-proof plastics containing said compounds as well as these compounds
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines
GB9317943D0 (en) Treatment of laminitis
GB9317989D0 (en) Treatment of laminitis
GB2269523B (en) Treating hides
HU9301187D0 (en) Method for treating tumours being dependent of gar-transformylase
EP0608702A3 (de) Verfahren zum Behandeln von Haselnüssen.
EP0932406A4 (en) METHODS OF TREATING OR PREVENTING INTERSTITIAL CYSTITIS
EP0654997A4 (en) COMPOSITIONS OF SUBSTITUTED AZASPIRANS AND METHOD FOR TREATING PSORIASIS THEREFOR.
GB9326020D0 (en) Novel method of treatment
GB9308853D0 (en) Novel method of treatment